Firesorb bioresorbable scaffold for de novo coronary artery disease: 1-year clinical outcomes

Abstract Background The first-generation bioresorbable scaffolds (BRS) have been associated with higher rates of device-related adverse outcomes in comparison to everolimus-eluting stents. We aimed to evaluate the efficacy and safety of the thinner-strut (100/125 μm) poly-L-lactic acid-based sirolim...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jun Jiang, Changling Li, Delong Chen, Lei Song, Zhanqian Cui, Ping Li, Lijun Gan, Yundai Chen, Hui Li, Shaobin Jia, Shenghu He, Wen Lu, Runlin Gao, Jianan Wang, on behalf of the FUTURE III Investigators
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2025-07-01
Edice:	BMC Medicine
Témata:	Bioresorbable scaffolds Coronary artery diseases Percutaneous coronary intervention Target lesion failure
On-line přístup:	https://doi.org/10.1186/s12916-025-04254-0
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!